A webinar was held on Friday, 13 November 2020 presenting a deep-dive on the positive first results of NBTXR3 in Immuno-Oncology. Moderated by Dr. Jeff Bockman, EVP, Oncology Practice Head, Cello Health, speakers include Laurent Levy, CEO, Nanobiotix, Dr. Colette Shen, Assistant Professor, Radiation Oncology and Dr. Jared Weiss, Assistant Professor of Medicine, both from UNC Lineberger Comprehensive Cancer Center and Dr. James Welsh, Radiation Oncologist & Professor, The University of Texas, MD Anderson Cancer Center.